These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 8862105)

  • 1. Epidemiology and outcome of Pseudomonas aeruginosa bacteremia, with special emphasis on the influence of antibiotic treatment. Analysis of 189 episodes.
    Vidal F; Mensa J; Almela M; Martínez JA; Marco F; Casals C; Gatell JM; Soriano E; Jimenez de Anta MT
    Arch Intern Med; 1996 Oct; 156(18):2121-6. PubMed ID: 8862105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pseudomonas aeruginosa bacteraemia. Is pancreatobiliary disease a risk factor?
    Chen SC; Lawrence RH; Byth K; Sorrell TC
    Med J Aust; 1993 Nov; 159(9):592-7. PubMed ID: 8232033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pseudomonas aeruginosa bacteremia: risk factors for mortality and influence of delayed receipt of effective antimicrobial therapy on clinical outcome.
    Kang CI; Kim SH; Kim HB; Park SW; Choe YJ; Oh MD; Kim EC; Choe KW
    Clin Infect Dis; 2003 Sep; 37(6):745-51. PubMed ID: 12955633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of an alternative cefepime dosing strategy in pulmonary and bloodstream infections caused by Enterobacter spp, Citrobacter freundii, and Pseudomonas aeruginosa: a single-center, open-label, prospective, observational study.
    Deal EN; Micek ST; Reichley RM; Ritchie DJ
    Clin Ther; 2009 Feb; 31(2):299-310. PubMed ID: 19302902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Prognostic factors of bacteremia: prospective study].
    Pazos Añón R; Fernández Rodríguez R; Paz Vidal I; Tinajas A; Cantón I; Abel V; González R; Martínez R; Gayoso P; Fernández Alvarez O
    An Med Interna; 2001 Aug; 18(8):415-20. PubMed ID: 11589079
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gram-negative bacteremia upon hospital admission: when should Pseudomonas aeruginosa be suspected?
    Schechner V; Nobre V; Kaye KS; Leshno M; Giladi M; Rohner P; Harbarth S; Anderson DJ; Karchmer AW; Schwaber MJ; Carmeli Y
    Clin Infect Dis; 2009 Mar; 48(5):580-6. PubMed ID: 19191643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pseudomonas aeruginosa bacteremia: clinical and epidemiological patterns and treatment].
    Gómez J; Alcántara M; Simarro E; Martínez B; Ruiz J; Guerra B; Gómez Vargas J; Valdés M
    Rev Esp Quimioter; 2002 Dec; 15(4):360-5. PubMed ID: 12587042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical significance and predictors of community-onset Pseudomonas aeruginosa bacteremia.
    Cheong HS; Kang CI; Wi YM; Kim ES; Lee JS; Ko KS; Chung DR; Lee NY; Song JH; Peck KR
    Am J Med; 2008 Aug; 121(8):709-14. PubMed ID: 18691485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemiology and prognosis of Pseudomonas aeruginosa bacteremia in a tertiary care center.
    Sifuentes-Osornio J; Gonzalez R; Ponce-de-Leon A; Guerrero ML
    Rev Invest Clin; 1998; 50(5):383-8. PubMed ID: 9949667
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Risk factors and prognosis of nosocomial pneumonia due to gram-negative bacteria in a general hospital].
    Martínez B; Gómez J; Gómez Vargas J; Gómez JR; Baños V; Sánchez ME; Canteras M; Valdés M
    Rev Esp Quimioter; 2000 Jun; 13(2):187-92. PubMed ID: 10918093
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pseudomonas aeruginosa bacteremia upon hospital admission: risk factors for mortality and influence of inadequate empirical antimicrobial therapy.
    Schechner V; Gottesman T; Schwartz O; Korem M; Maor Y; Rahav G; Karplus R; Lazarovitch T; Braun E; Finkelstein R; Lachish T; Wiener-Well Y; Alon D; Chowers M; Bardenstein R; Zimhony O; Paz A; Potasman I; Giladi M; Schwaber MJ; Klarfeld-Lidji S; Hochman M; Marchaim D; Carmeli Y
    Diagn Microbiol Infect Dis; 2011 Sep; 71(1):38-45. PubMed ID: 21763093
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of 30-day mortality among patients with Pseudomonas aeruginosa bloodstream infections: impact of delayed appropriate antibiotic selection.
    Lodise TP; Patel N; Kwa A; Graves J; Furuno JP; Graffunder E; Lomaestro B; McGregor JC
    Antimicrob Agents Chemother; 2007 Oct; 51(10):3510-5. PubMed ID: 17646415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical predictors of Pseudomonas aeruginosa bacteremia among Gram-negative bacterial infections in non-neutropenic patients with solid tumor.
    Joo EJ; Kang CI; Ha YE; Kim J; Kang SJ; Park SY; Lee NY; Wi YM; Chung DR; Peck KR; Song JH
    J Infect; 2011 Sep; 63(3):207-14. PubMed ID: 21777616
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimal management therapy for Pseudomonas aeruginosa ventilator-associated pneumonia: an observational, multicenter study comparing monotherapy with combination antibiotic therapy.
    Garnacho-Montero J; Sa-Borges M; Sole-Violan J; Barcenilla F; Escoresca-Ortega A; Ochoa M; Cayuela A; Rello J
    Crit Care Med; 2007 Aug; 35(8):1888-95. PubMed ID: 17581492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bloodstream infections due to extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae: risk factors for mortality and treatment outcome, with special emphasis on antimicrobial therapy.
    Kang CI; Kim SH; Park WB; Lee KD; Kim HB; Kim EC; Oh MD; Choe KW
    Antimicrob Agents Chemother; 2004 Dec; 48(12):4574-81. PubMed ID: 15561828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors and outcome of Pseudomonas aeruginosa bacteremia among adults visiting the ED.
    Lee CC; Lee CH; Hong MY
    Am J Emerg Med; 2012 Jul; 30(6):852-60. PubMed ID: 21855263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bacteremia due to Stenotrophomonas maltophilia in patients with hematologic malignancies.
    Micozzi A; Venditti M; Monaco M; Friedrich A; Taglietti F; Santilli S; Martino P
    Clin Infect Dis; 2000 Sep; 31(3):705-11. PubMed ID: 11017819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pseudomonas aeruginosa bacteremia in patients with HIV infection: clinicoepidemiologic study of 17 episodes].
    Salavert Lletí S; Navarro Ibáñez V; Roig Rico P; Bretón Martínez JR; Ponz Díez F; López Aldeguer J; Gobernado Serrano M
    Rev Clin Esp; 1996 Oct; 196(10):684-91. PubMed ID: 9005471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. P. aeruginosa bloodstream infections among hematological patients: an old or new question?
    Cattaneo C; Antoniazzi F; Casari S; Ravizzola G; Gelmi M; Pagani C; D'Adda M; Morello E; Re A; Borlenghi E; Manca N; Rossi G
    Ann Hematol; 2012 Aug; 91(8):1299-304. PubMed ID: 22349723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple-drug-resistant bacteria in patients with severe acute exacerbation of chronic obstructive pulmonary disease: Prevalence, risk factors, and outcome.
    Nseir S; Di Pompeo C; Cavestri B; Jozefowicz E; Nyunga M; Soubrier S; Roussel-Delvallez M; Saulnier F; Mathieu D; Durocher A
    Crit Care Med; 2006 Dec; 34(12):2959-66. PubMed ID: 17012911
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.